PHM-Exch> Fwd: [e-drug] Upcoming Summer Courses Utrecht 2019 - registration now open

[김선]

> 전달된 메시지 시작:
> 
> 보낸 사람: "Ham, H.A. van den (Rianne)" <H.A.vandenHam at uu.nl>
> 제목: [e-drug] Upcoming Summer Courses Utrecht 2019 - registration now open
> 날짜: 2019년 3월 13일 오전 1시 25분 8초 GMT+9
> 받는 사람: "'e-drug at healthnet.org'" <e-drug at healthnet.org>
> 참조: "Mantel-Teeuwisse, A.K. \(Aukje\)" <A.K.Mantel at uu.nl>
> 답장 받는 사람: Essential Drugs in English <e-drug at healthnet.org>
> 
> E-DRUG: Upcoming Summer Courses Utrecht 2019 - registration now open
> -------------------------------------------------------------------------------------------
> 
> Dear colleagues,
> 
> This summer, the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University, the Netherlands, offers you two challenging international summer courses:
> 
> 8 -12 July 2019 - Pharmacoepidemiology & Drug safety
> 
> 15-19 July 2019 - Pharmaceutical Policy Analysis (organized by the WHO CC Pharmaceutical Policy and Regulation in collaboration with WHO)
> 
> All courses will cover the key issues in each field and focus on the most important research methods used. All course teachers have extensive expertise in their field. More detailed information can be found below or on the summer school website (www.utrechtsummerschool.nl<http://www.utrechtsummerschool.nl>). Registration takes place through this website as well. Our experience is that courses fill up quickly, so register as soon as possible.
> 
> A few scholarships are available for the Pharmaceutical Policy Analysis course for participants from low and middle income countries. These scholarships include course fee and basic student housing as described on the summer school website. International travel is at the expense of the applicant or his/her institution. If you wish to apply for a scholarship, please do so before 28 April 2019 by sending an application letter including motivation plus CV to 
> Rianne van den Ham 
> h.a.vandenham at uu.nl
> 
> All applicants will be notified by 11 May 2019.
> 
> Supplementary, there is a cultural and social programme arranged for you to make sure that you experience the best of Utrecht. We look forward to welcoming you!
> 
> On behalf of the other course directors,
> 
> Best wishes,
> Rianne van den Ham
> 
> M7 Pharmaceutical Policy Analysis (15-19 July 2019)
> 
> Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
> 
> The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
> 
> You will experience an intensive programme covering the following topics:
> Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation;
> universal health coverage; regulatory issues and challenges; country profiles;  policy and politics; synthesis, case studies & public health.
> 
> Course directors
> Prof. Dr. Bert Leufkens, Prof. Dr. Aukje Mantel, Dr. Rianne van den Ham and other UU and WHO staff members
> 
> M8 Pharmacoepidemiology & Drug Safety (8-12 July 2019)
> 
> With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of 'safety', proof of 'effectiveness'). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs 'efficacy'.
> 
> The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology.  Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.
> 
> You will experience an intensive programme covering the following topics: Study Design and Methods; Confounding and other biases; Methods in drug safety research; drug safety and risk management; overview of pharmacoepidemiological databases; molecular pharmacoepidemiology; drug utilization research; synthesis, case studies & public health.
> 
> Course director
> Prof. O.H. Klungel
> 
> Lecturers
> Prof. S. Suissa, Prof. H.G.M. Leufkens, Prof. A. de Boer, Prof. A.C.G. Egberts, Prof. T.P. van Staa, Dr. F. de Vries, Dr. H. Gardarsdottir, Dr. R. Pajouheshnia
> 
> General information for all courses
> 
> Target groups
> (Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine, who have an interest in the policy aspects of pharmaceuticals and/or pharmacoepidemiology.
> 
> Fee and combinations
> E 975,- per course (including course materials + lunches + course dinner, excluding housing). Combination fee for two courses is E1550,- (excluding housing).
> 
> Deadline for application
> 1 July 2019, see www.utrechtsummerschool.nl (information summer school and course registration)
> 
> More information
> Course assistant: Maud Vromen (pharm.summercourses at gmail.com)
> 
> Scholarships for M7 Pharmaceutical Policy Analysis
> 
> A few scholarships are available for the Pharmaceutical Policy Analysis course for participants from low and middle income countries. These scholarships include course fee and basic student housing as described on the summer school website. International travel is at the expense of the applicant or his/her institution. If you wish to apply for a scholarship, please do so before 28 April 2019 by sending an application letter including motivation plus CV to 
> Rianne van den Ham 
> h.a.vandenham at uu.nl
> All applicants will be notified by 11 May 2019.
> 
> Rianne van den Ham, PhD�
> Postdoctoral researcher, 
> WHO Collaborating Centre Pharmaceutical Policy and Regulation
> Division of Pharmacoepidemiology & Clinical Pharmacology
> Utrecht Institute for Pharmaceutical Sciences
> Netherlands
> h.a.vandenham at uu.nl
> _______________________________________________
> E-Drug, an e-forum on essential drugs, is moderated by a team of 
> international experts and hosted by FHI 360
> 
> To subscribe:  e-drug-join at healthnet.org
> To unsubscribe:  e-drug-leave at healthnet.org
> To discuss (subscribers only):  e-drug at healthnet.org
> For help:  e-drug-owner at healthnet.org
> For archives:  http://lists.healthnet.org/archive/html/e-drug/

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20190313/c5a62834/attachment.html>